Just like the novel coronavirus itself, the emergence of so-called long COVID has surprised both the patients who couldn’t shake their symptoms and the clinicians who have struggled to provide effective treatments. Now, as the U.S. looks to move past the pandemic, there remain unanswered questions about how this fallout from the virus might hamper some workers and for how long. These uncertainties could have important implications for workers’ compensation. By some measures, one in four patients who get COVID-19—even those with mild or asymptomatic cases—will experience subsequent symptoms that range from muscle and nerve pain to breathing difficulties to anxiety and depression. The scope of the challenge will require providers and employers to better understand the nature of the conditions, their origins, and the best paths for treatment. Watch this on-demand webinar to learn more about long COVID and the implications for workers and employers.
More stories
Telemedicine - Telehealth
Once upon a very different time, doctors arrived at one’s doorstep carrying a black bag packed with a thermometer, a stethoscope, and other tools — but that hasn’t been standard operating procedure for recent generations. Today, millennials and others who have never had a health care provider in their living room are benefiting from virtual house calls, which can help increase access to clinicians, facilitate appropriate care and support better outcomes. Marrying clinical support and technology can have many benefits, and it is time to apply them to workers’ compensation.
Seeing Red: Warning Signs of off-track claims
Red flags in workers comp’ case management are indicators signaling potential problems that could adversely impact an injured empl
Case Management and You: What to Expect & What to Demand
Case Study: Food and Beverage
Genex returned injured food and beverage industry workers to their jobs more than five weeks faster than the At-Risk Date from the ODG claims datab
Medicare Set-Aside Government Case Study
Medicare Set Aside was reduced from $677,573 to $77,897 Industry: Government
Medication Safety Program Case Study
Proactive Opioid Management Saves $1.4M Genex’s Medication Safety Program empowers employers and workers’ compensation payers to bala